Medicine for treating ataxia hereditaria

Abstract

The invention relates to a medicine for treating ataxia hereditaria. The medicine is prepared from the following medicinal raw materials in parts by weight: 18 parts of uncaria rhynchophylla, 5 parts of fructus alpiniae oxyphyllae, 3 parts of fructus evodiae, 12 parts of Chinese wolfberry fruits, 12 parts of astragalus membranaceus, 12 parts of habenaria ciliolaris, 12 parts of radix scrophulariae and 6 parts of fructus psoraleae. The medicine applies uncaria rhynchophylla with effects of clearing heat, soothing liver, calming endogenous wind and relieving spasm, fructus alpiniae oxyphyllae with effects of nourishing liver and kidneys and replenishing essence to benefit brain, fructus evodiae with effects of dispelling cold, relieving pain, soothing liver, depressing qi, warming middle-warmer and drying dampness, Chinese wolfberry fruits with effects of nourishing liver and kidneys, astragalus membranaceus with effects of tonifying spleen and qi, nourishing kidneys and replenishing essence, habenaria ciliolaris with effects of strengthening low back and tonifying kidneys, radix scrophulariae with effects of clearing heat, cooling blood, nourishing yin and lowering internal heat, and fructus psoraleae with effects of strengthening tendons and bones. The medicinal materials are combined to achieve the effects of tonifying kidneys and spleen, warmly nourishing kidneys and Du meridians and strengthening tendons and bones. Clinical experiments prove that the medicine can be used for safely and effectively treating ataxia hereditaria.

Description

technical field [0001] The invention relates to a traditional Chinese medicine, in particular to a medicine for treating hereditary ataxia. Background technique [0002] Hereditary ataxia (HA) is a group of hereditary degenerative diseases of the central nervous system with slowly progressive ataxia as the main clinical manifestation. The lesion is mainly in the spinal cord, cerebellum, and brainstem, so it is also called spinocerebellar-brainstem disease, also known as spinocerebellar ataxia (spinocerehenar ataxia, SCAs). More than adult onset (over 30 years old), it manifests as balance disorder, progressive limb coordination disorder, gait instability, dysarthria, eye movement disorder, etc., and may be accompanied by complex nervous system damage, such as pyramidal system, cone External system, vision, hearing, spinal cord, and peripheral nerve damage may also be accompanied by cerebral cortex damage such as cognitive dysfunction and (or) abnormal mental behavior. It m...

AI Technical Summary

Problems solved by technology

[0023] ①At present, there is no western medicine that can completely prevent the progression of hereditary ataxia. The clinical treatment of hereditary ataxia is still based on empiric symptomatic treatment.